Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 18 September 2017. Database contains 336 unique substances/entries.
Filter the list

 
215-609-9
1333-86-4
2019
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
215-175-0
1309-64-4
2018
Germany
Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Ongoing
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Ongoing
Details
219-514-3
2451-62-9
2015
Poland
CMR
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
203-002-1
102-06-7
2012
France
CMR
High (aggregated) tonnage
High RCR
Information requested
Details
204-077-3
115-27-5
2013
France
CMR
Exposure of environment
Exposure of workers
Suspected PBT/vPvB
Suspected Sensitiser
Information requested
Details
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Information requested
Details
205-743-6
149-57-5
2012
Spain
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
249-204-3
28768-32-3
2013
Denmark
CMR
Wide dispersive use
Follow-up
Details
500-415-1
158885-29-1
2018
Estonia
Consumer use
CMR
High (aggregated) tonnage
Sensitiser
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
500-312-1
123714-19-2
2018
Estonia
Consumer use
CMR
High (aggregated) tonnage
Sensitiser
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
202-966-0
101-68-8
2013
Estonia
Consumer use
CMR
Sensitiser
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
203-253-7
104-93-8
2012
Ireland
CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
205-736-8
149-30-4
2013
Germany
CMR
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
202-496-6
96-29-7
2013
Germany
Consumer use
Cumulative exposure
CMR
High RCR
Sensitiser
Wide dispersive use
Concluded
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Information requested
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Information requested
Details
200-817-4
74-87-3
2012
Italy
CMR
Potential endocrine disruptor
High RCR
Conclusion under preparation
Details
203-733-6
110-05-4
2016
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
205-016-3
131-17-9
2013
Spain
Consumer use
CMR
Wide dispersive use
Information requested
Details
201-550-6
84-66-2
2014
Germany
Consumer use
CMR
High (aggregated) tonnage
Potential endocrine disruptor
Wide dispersive use
Concluded
Details
212-783-8
868-85-9
2012
Netherlands
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-626-1
98-00-0
2013
Poland
Consumer use
CMR
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
204-617-8
123-31-9
2012
Italy
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
206-019-2
288-32-4
2012
United Kingdom
CMR
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
247-722-4
26471-62-5
2012
Poland
CMR
Suspected PBT/vPvB
Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-785-7
99-76-3
2014
France
Consumer use
CMR
Exposure of sensitive populations
High (aggregated) tonnage
Potential endocrine disruptor
Wide dispersive use
Information requested
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
203-777-6
110-54-3
2012
Germany
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
272-486-4
68855-45-8
2016
France
CMR
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
272-234-3
68784-26-9
2013
Netherlands
Consumer use
CMR
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
905-806-4
-
2015
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
204-825-9
127-18-4
2013
Latvia
CMR
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Concluded
Details
203-726-8
109-99-9
2013
Germany
Consumer use
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
236-675-5
13463-67-7
2018
France
CMR
Suspected Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Not started
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-800-2
126-73-8
2012
Hungary
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
242-060-2
127-91-3, 18172-67-3
2014
Greece
Consumer use
High (aggregated) tonnage
Sensitiser
Wide dispersive use
Concluded
Details
203-820-9
110-97-4
2013
Czech Republic
Consumer use
Exposure of workers
High RCR
Suspected CMR
Suspected Sensitiser
Wide dispersive use
Concluded
Details
211-463-5
646-06-0
2016
Germany
Suspected Mutagenic
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
273-227-8
68953-84-4
2013
Germany
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-707-1
98-85-1
2018
Italy
Suspected Carcinogenic
Suspected Mutagenic
Wide dispersive use
Consumer use
Exposure of workers
Not started
Details

Export search results to:


Route: .live1

This website uses cookies to ensure you get the best experience on our websites.

Find out more on how we use cookies.